Nanoparticles for skin penetration enhancement - A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 2, 2009, Pages 243-250

  Küchler, Sarah ^a   Radowski, Michal R ^a   Blaschke, Tobias ^a   Dathe, Margitta ^b   Plendl, Johanna ^a   Haag, Rainer ^a   Schäfer Korting, Monika ^a   Kramer, Klaus D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Cellular uptake; Dendritic core multishell nanotransporters; Nile red; Skin penetration; Solid lipid nanoparticles

Indexed keywords

GLYCEROL BEHENATE; NANOCARRIER; SOLID LIPID NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CREAM; DEGRADATION; EPIDERMIS; EX VIVO STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; KERATINOCYTE; LASER MICROSCOPY; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SKIN PENETRATION; STRATUM CORNEUM; SWINE; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; DENDRIMERS; FLUORESCENT DYES; HUMANS; KERATINOCYTES; LIPIDS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; OXAZINES; PARTICLE SIZE; SKIN; SKIN ABSORPTION; SWINE;

EID: 59649122150     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.08.019     Document Type: Article

References (51)

1. Schäfer-Korting M., Mehnert W., and Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007) 427-443
2. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56 (2004) 675-711
3. Choi M.J., and Maibach H.I. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol. Physiol. 18 (2005) 209-219
4. Müller R.H., Radtke M., and Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 Suppl. 1 (2002) S131-155
5. Kogan A., and Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123-126 (2006) 369-385
6. Lopes L.B., Ferreira D.A., de Paula D., Garcia M.T., Thomazini J.A., Fantini M.C., and Bentley M.V. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res. 23 (2006) 1332-1342
7. Bouwstra J.A., and Honeywell-Nguyen P.L. Skin structure and mode of action of vesicles. Adv. Drug Deliv. Rev. 54 Suppl. 1 (2002) S41-S55
8. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Röder B., Kramer K.D., and Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 110 (2005) 151-163
9. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., and Schäfer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res. 24 (2007) 991-1000
10. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., and Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 97 (2004) 493-502
11. Shah K.A., Date A.A., Joshi M.D., and Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 345 (2007) 163-171
12. Masini V., Bonte F., Meybeck A., and Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J. Pharm. Sci. 82 (1993) 17-21
13. Schäfer-Korting M., Korting H.C., and Ponce-Pöschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Investig. 72 (1994) 1086-1091
14. Schäfer-Korting M., Kleuser B., Ahmed M., Höltje H.D., and Korting H.C. Glucocorticoids for human skin: new aspects of the mechanism of action. Skin Pharmacol. Physiol. 18 (2005) 103-114
15. Fesq H., Lehmann J., Kontny A., Erdmann I., Theiling K., Rother M., Ring J., Cevc G., and Abeck D. Improved risk-benefit ratio for topical triamcinolone acetonide in transfersome in comparison with equipotent cream and ointment: a randomized controlled trial. Br. J. Dermatol. 149 (2003) 611-619
16. Embil K., and Nacht S. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J. Microencapsul. 13 (1996) 575-588
17. Wester R.C., Patel R., Nacht S., Leyden J., Melendres J., and Maibach H. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol. 24 (1991) 720-726
18. Hadjikirova M., Troyanova P., and Simeonova M. Nanoparticles as drug carrier system of 5-fluorouracil in local treatment of patients with superficial basal cell carcinoma. J. Buon. 10 (2005) 517-521
19. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21 (2004) 1818-1825
20. Haag R. Supramolecular drug-delivery systems based on polymeric core-shell architectures. Angew. Chem. Int. Ed. Engl. 43 (2004) 278-282
21. Radowski M.R., Shukla A., von Berlepsch H., Bottcher C., Pickaert G., Rehage H., and Haag R. Supramolecular aggregates of dendritic multishell architectures as universal nanocarriers. Angew. Chem. Int. Ed. Engl. 46 (2007) 1265-1269
22. Stasko N.A., Johnson C.B., Schoenfisch M.H., Johnson T.A., and Holmuhamedov E.L. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules 8 (2007) 3853-3859
23. Roller S., Zhou H., and Haag R. High-loading polyglycerol supported reagents for Mitsunobu- and acylation-reactions and other useful polyglycerol derivatives. Mol. Divers. 9 (2005) 305-316
24. Sunder A., Hanselmann R., Frey H., and Mülhaupt R. Controlled synthesis of hyperbranched polyglycerols by ring-opening multibranching polymerization. Macromolecules 32 (1999) 4240-4246
25. Schäfer-Korting M., Bock U., Gamer A., Haberland A., Haltner-Ukomadu E., Kaca M., Kamp H., Kietzmann M., Korting H.C., Krächter H.U., Lehr C.M., Liebsch M., Mehling A., Netzlaff F., Niedorf F., Rübbelke M.K., Schäfer U., Schmidt E., Schreiber S., Schröder K.R., Spielmann H., and Vuia A. Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. ATLA 34 (2006) 283-294
26. Gysler A., Lange K., Korting H.C., and Schäfer-Korting M. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm. Res. 14 (1997) 793-797
27. Blaschke T., Kankate L., and Kramer K.D. Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. Adv. Drug Deliv. Rev. 59 (2007) 403-410
28. Schäfer-Korting M., Bock U., Diembeck W., Düsing H.J., Gamer A., Haltner-Ukomadu E., Hoffmann C., Kaca M., Kamp H., Kersen S., Kietzmann M., Korting H.C., Krächter H.U., Lehr C.M., Liebsch M., Mehling A., Müller-Goymann C., Netzlaff F., Niedorf F., Rübbelke M.K., Schäfer U., Schmidt E., Schreiber S., Spielmann H., Vuia A., and Weimer M. The use of reconstructed human epidermis for skin absorption testing: results of the validation study. ATLA 36 (2008) 161-187
29. Stella B., Marsaud V., Arpicco S., Geraud G., Cattel L., Couvreur P., and Renoir J.M. Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models. J. Drug Target. 15 (2007) 146-153
30. Magnusson B.M., Anissimov Y.G., Cross S.E., and Roberts M.S. Molecular size as the main determinant of solute maximum flux across the skin. J. Invest. Dermatol. 122 (2004) 993-999
31. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99 (2004) 53-62
32. Glasstone S., Laidler K.J., and Eyring H. (1941), McGraw-Hill, New York
33. Sivaramakrishnan R., Kankate L., Niehus H., and Kramer K. Parelectric spectroscopy of drug-carrier systems - distribution of carrier masses or activation. Biophys. Chem. 114 (2003) 221-228
34. Lorenz M.R., Holzapfel V., Musyanovych A., Nothelfer K., Walther P., Frank H., Landfester K., Schrezenmeier H., and Mailander V. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27 (2006) 2820-2828
35. Braem C., Blaschke T., Panek-Minkin G., Herrmann W., Schlupp P., Paepenmüller T., Müller-Goyman C., Mehnert W., Bittl R., Schäfer-Korting M., and Kramer K.D. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J. Control Release 119 (2007) 128-135
36. Jores K., Haberland A., Wartewig S., Mader K., and Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm. Res. 22 (2005) 1887-1897
37. Wissing S., and Müller R. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm. 242 (2002) 377-379
38. Mididoddi P.K., and Repka M.A. Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur. J. Pharm. Biopharm. 66 (2007) 95-105
39. H. Schaefer, F. Watts, J. Brod, B. Illel, in: R.C. Scott, R.H. Guy, J. Hadgraft (Eds.), Prediction of Percutaneous Penetration. Methods, Measurments, Modeling, IBC Techncal Services 1990, pp. 163-173.
40. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., and Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 123 (2004) 168-176
41. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., and Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 10 (2002) 489-495
42. Pierre M.B., Tedesco A.C., Marchetti J.M., and Bentley M.V. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 1 (2001) 5
43. Schaller M., Korting H.C., and Schmid M.H. Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles. Br. J. Dermatol. 134 (1996) 445-450
44. Schaller M., Wurm R., and Korting H.C. Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis. Antimicrob. Agents Chemother. 41 (1997) 717-719
45. Edetsberger M., Gaubitzer E., Valic E., Waigmann E., and Kohler G. Detection of nanometer-sized particles in living cells using modern fluorescence fluctuation methods. Biochem. Biophys. Res. Commun. 332 (2005) 109-116
46. Innes N.P., and Ogden G.R. A technique for the study of endocytosis in human oral epithelial cells. Arch. Oral Biol. 44 (1999) 519-523
47. Miglietta A., Cavalli R., Bocca C., Gabriel L., and Gasco M.R. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int. J. Pharm. 210 (2000) 61-67
48. Greenspan P., and Fowler S.D. Spectrofluorometric studies of the lipid probe, nile red. J. Lipid Res. 26 (1985) 781-789
49. Clarke B.L., and Weigel P.H. Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. J. Biol. Chem. 260 (1985) 128-133
50. Ukkonen P., Saraste J., Korpela K., Pesonen M., and Kaariainen L. Temperature-dependent internalization of virus glycoproteins in cells infected with a mutant of Semliki Forest virus. EMBO J. 1 (1982) 191-196
51. Huang K., Voss B., Kumar D., Hamm H.E., and Harth E. Dendritic molecular transporters provide control of delivery to intracellular compartments. Bioconjug. Chem. 18 (2007) 403-409